QDEL [NASD]
QuidelOrtho Corporation
Index- P/E3.33 EPS (ttm)21.59 Insider Own1.10% Shs Outstand52.20M Perf Week-1.94%
Market Cap4.85B Forward P/E13.37 EPS next Y5.38 Insider Trans0.00% Shs Float49.30M Perf Month-11.26%
Income1.01B PEG0.46 EPS next Q1.34 Inst Own95.50% Short Float6.49% Perf Quarter-33.18%
Sales2.76B P/S1.76 EPS this Y-11.70% Inst Trans51.66% Short Ratio4.55 Perf Half Y-37.73%
Book/sh94.25 P/B0.76 EPS next Y-56.60% ROA24.50% Target Price122.67 Perf Year-46.24%
Cash/sh6.40 P/C11.24 EPS next 5Y7.20% ROE36.90% 52W Range68.43 - 180.06 Perf YTD-46.72%
Dividend- P/FCF5.18 EPS past 5Y110.10% ROI36.80% 52W High-60.06% Beta0.16
Dividend %- Quick Ratio1.10 Sales past 5Y54.70% Gross Margin70.30% 52W Low5.10% ATR2.92
Employees1600 Current Ratio1.70 Sales Q/Q247.30% Oper. Margin48.30% RSI (14)35.62 Volatility3.31% 3.52%
OptionableYes Debt/Eq0.56 EPS Q/Q-18.90% Profit Margin36.40% Rel Volume0.93 Prev Close73.52
ShortableYes LT Debt/Eq0.51 EarningsAug 04 AMC Payout0.00% Avg Volume702.14K Price71.92
Recom2.30 SMA20-7.31% SMA50-14.96% SMA200-29.01% Volume651,145 Change-2.18%
Sep-19-22Initiated Citigroup Neutral $90
Jul-20-22Initiated UBS Sell $86
Jun-17-22Resumed JP Morgan Neutral $80 → $110
Feb-22-22Upgrade Raymond James Outperform → Strong Buy $155 → $130
Jan-22-21Upgrade Raymond James Mkt Perform → Outperform $250
May-12-20Downgrade JP Morgan Neutral → Underweight $120 → $158
Mar-26-20Downgrade Barclays Overweight → Equal Weight $90
Oct-23-18Resumed Raymond James Strong Buy $80
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Oct-04-22 09:00AM
Sep-06-22 08:00AM
Sep-03-22 09:00AM
Sep-02-22 06:46AM
Sep-01-22 12:00PM
09:00AM Loading…
Aug-24-22 09:00AM
Aug-17-22 04:30PM
Aug-12-22 01:27PM
Aug-09-22 12:08PM
Aug-04-22 04:10PM
Jul-27-22 07:24AM
Jul-26-22 09:35AM
09:35AM
Jul-24-22 05:30AM
Jul-18-22 04:05PM
03:57PM Loading…
Jul-04-22 03:57PM
Jun-29-22 12:06PM
Jun-21-22 07:00PM
Jun-09-22 09:00AM
09:00AM
Jun-03-22 11:32AM
Jun-01-22 08:56AM
May-27-22 09:00AM
May-26-22 12:24PM
12:05PM
May-19-22 06:28AM
May-16-22 04:45PM
04:45PM
May-05-22 11:21AM
09:52AM
05:55PM Loading…
May-04-22 05:55PM
04:10PM
01:49PM
Apr-30-22 10:43AM
Apr-26-22 11:48AM
Apr-25-22 05:45PM
Apr-13-22 05:45PM
Apr-12-22 06:00PM
05:50PM
10:10AM
Apr-08-22 05:50AM
Apr-07-22 04:10PM
Apr-06-22 05:45PM
08:30AM
Mar-31-22 05:45PM
Mar-25-22 05:45PM
Mar-23-22 05:50PM
Mar-22-22 11:36AM
Mar-21-22 01:04PM
Mar-17-22 10:00AM
Mar-15-22 10:00AM
08:30AM
Mar-11-22 05:45PM
10:32AM
10:00AM
Mar-10-22 10:51AM
07:56AM
Mar-07-22 09:40AM
Mar-05-22 12:03AM
Mar-04-22 10:52AM
Mar-03-22 09:17AM
Mar-02-22 12:53PM
08:51AM
Mar-01-22 02:43PM
11:37AM
Feb-28-22 06:30PM
10:26AM
10:16AM
09:40AM
Feb-25-22 08:30AM
Feb-24-22 08:31AM
08:27AM
Feb-23-22 10:00AM
Feb-22-22 03:54PM
Feb-18-22 11:38AM
11:28AM
06:48AM
05:47AM
Feb-17-22 06:15PM
04:10PM
Feb-14-22 10:42AM
Feb-10-22 03:01PM
08:45AM
Feb-08-22 05:45PM
11:35AM
09:38AM
Feb-07-22 12:28PM
Feb-04-22 03:00AM
Feb-02-22 09:38AM
Feb-01-22 04:10PM
01:38PM
Jan-31-22 05:45PM
08:52AM
07:41AM
Jan-26-22 10:00AM
Jan-24-22 11:31AM
Jan-12-22 03:08PM
11:20AM
Jan-11-22 05:50PM
10:10AM
QuidelOrtho Corporation provides various in vitro diagnostics products worldwide. The company's product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and clinical and at-home products to detect COVID-19. It provides visually-read lateral flow products in infectious disease and reproductive health; direct fluorescent antibodies in infectious disease and virology; micro-titer production with a focus on bone and complement pathway markets; fluorescent immunoassay products; molecular diagnostic products comprising Savanna, an integrated molecular diagnostic system; immunodiagnostics, clinical chemistry, and integrated testing systems to serve diagnostic labs of all sizes; immunodiagnostic donor screening systems and services that drive blood safety; pre-transfusion testing that automates blood bank workload with software to standardize operations, simplify tasks, and improve productivity; and Ortho Care services and informatics products. The company was founded in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilkins Joseph D Jr.DirectorMay 18Option Exercise0.001,62401,913May 20 07:53 PM
WIDDER KENNETH JDirectorMay 18Option Exercise0.001,624018,684May 20 07:51 PM
Strobeck MatthewDirectorMay 18Option Exercise0.001,62406,533May 20 07:50 PM
RHOADS ANN DDirectorMay 18Option Exercise0.001,62402,248May 20 07:48 PM
POLAN MARY LAKE PH DDirectorMay 18Option Exercise0.001,624020,653May 20 07:46 PM
Michael Edward L.DirectorMay 18Option Exercise0.001,62409,098May 20 07:45 PM
BUECHLER KENNETH FDirectorMay 18Option Exercise0.001,624070,288May 20 07:43 PM
WIDDER KENNETH JDirectorMay 15Option Exercise0.001,028017,060May 17 07:55 PM
POLAN MARY LAKE PH DDirectorMay 15Option Exercise0.00867019,029May 17 07:49 PM
BUECHLER KENNETH FDirectorMay 10Option Exercise15.737,800122,69468,664May 12 08:12 PM
POLAN MARY LAKE PH DDirectorMar 18Sale113.591,525173,22718,162Mar 22 07:57 PM
SLACIK CHARLES PDirectorJan 25Option Exercise19.5412,086236,12324,067Jan 27 07:27 PM